207
Views
22
CrossRef citations to date
0
Altmetric
Original Research

Incidence, risk factors, and prognosis in patients with primary hepatocellular carcinoma and lung metastasis: a population-based study

, &
Pages 2759-2768 | Published online: 08 Apr 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Juxian Sun, Chang Liu, Nanya Wang, Dafeng Jiang, Fan Zhang, Jie Shi & Shuqun Cheng. (2022) All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study. Cancer Management and Research 14, pages 1663-1670.
Read now

Articles from other publishers (21)

Hanlong Zhu, Si Zhao, Tianming Zhao, Lu Chen, Shupei Li, Kun Ji, Kang Jiang, Hui Tao, Ji Xuan, Miaofang Yang, Bing Xu, Mingzuo Jiang & Fangyu Wang. (2024) Comparison of metastasis and prognosis between early-onset and late-onset hepatocellular carcinoma: A population-based study. Heliyon 10:7, pages e28497.
Crossref
Juntao Tan, Yue Yu, Xiantian Lin, Yuxin He, Wen Jin, Hong Qian, Ying Li, Xiaomei Xu, Yuxi Zhao, Jianwen Ning, Zhengyu Zhang, Jingjing Chen & Xiaoxin Wu. (2023) OHCCPredictor: an online risk stratification model for predicting survival duration of older patients with hepatocellular carcinoma. Hepatology International 18:2, pages 550-567.
Crossref
Jiaoyu Ai, Wanlin Zhang, Wensheng Deng, Likun Yan, Lidong Zhang, Zongjing Huang, Ziyi Wu, Junhua Ai & Hai Jiang. (2024) A hsa_circ_001726 axis regulated by E2F6 contributes to metastasis of hepatocellular carcinoma. BMC Cancer 24:1.
Crossref
Halima H. Al-Shuaili, Said A. Al-Busafi, Khalid Al-Naamani & Zakariya Al-Naamani. (2024) Predictors of survival among patients with chronic hepatitis C at a tertiary care center in Oman. Saudi Journal of Gastroenterology 30:1, pages 45-52.
Crossref
Anna Fichtl, Thomas Seufferlein & Eugen Zizer. (2023) Risks and benefits of TIPS in HCC and other liver malignancies: a literature review. BMC Gastroenterology 23:1.
Crossref
Guangzhao Shao, Yao Zhi, Zhongqi Fan, Wei Qiu & Guoyue Lv. (2023) Development and validation of a diagnostic and prognostic model for lung metastasis of hepatocellular carcinoma: a study based on the SEER database. Frontiers in Medicine 10.
Crossref
Lei Wang, Jin-Lin Peng & Ji-Zhou Wu. (2023) Nomogram to predict the prognosis of patients with AFP-negative hepatocellular carcinoma undergoing chemotherapy: A SEER based study. Medicine 102:13, pages e33319.
Crossref
Xia Zou, Jishun Lu, Yao Deng, Qiannan Liu, Xialin Yan, Yalu Cui, Xiao Xiao, Meng Fang, Fang Yang, Hiromichi Sawaki, Takashi Sato, Binbin Tan, Xiaoyan Lu, Bo Feng, Atsushi Kuno, Hisashi Narimatsu, Chunfang Gao & Yan Zhang. (2022) ST6GAL1 inhibits metastasis of hepatocellular carcinoma via modulating sialylation of MCAM on cell surface. Oncogene 42:7, pages 516-529.
Crossref
A. S. Shkaraburov, D. N. Rudenko, E. F. Vaiman, O. M. Soboleva & Yu. V. Zakharova. (2022) Asymptomatic Hepatocellular Carcinoma (Clinical Case). Creative surgery and oncology 12:3, pages 256-260.
Crossref
Yu-Qi Wang, An-Jiang Wang, Ting-Ting Zhang & Si-Hai Chen. (2022) Association of alpha-fetoprotein and metastasis for small hepatocellular carcinoma: A propensity-matched analysis. Scientific Reports 12:1.
Crossref
Xiaolong Lv, Lei Yang, Tianyu Liu, Zelin Yang, Chenhao Jia & Huanwen Chen. (2022) Pan-cancer analysis of the prevalence and associated factors of lung metastasis and the construction of the lung metastatic classification system. Frontiers in Surgery 9.
Crossref
Wei Zhang, Lichen Ji, Xugang Zhong, Senbo Zhu, Yi Zhang, Meng Ge, Yao Kang & Qing Bi. (2022) Two Novel Nomograms Predicting the Risk and Prognosis of Pancreatic Cancer Patients With Lung Metastases: A Population-Based Study. Frontiers in Public Health 10.
Crossref
Feiyang Zhong, Zhenxing Liu, Binchen Wang, Wenting An, Hanfei Zhang, Meiyan Liao & Sufang Tian. (2022) A Predictive Model to Differentiate Between Second Primary Lung Cancers and Pulmonary Metastasis. Academic Radiology 29, pages S137-S144.
Crossref
Shengqiang Zhang, Jida Guo, Hongyan Zhang, Huawei Li, Mohamed Osman Omar HassanLinyou Zhang. (2021) Metastasis pattern and prognosis in men with esophageal cancer patients. Medicine 100:25, pages e26496.
Crossref
Yidi Chen, Yuwei Xia, Parag P. Tolat, Liling Long, Zijian Jiang, Zhongkui Huang & Qin Tang. (2021) Comparison of Conventional Gadoxetate Disodium–Enhanced MRI Features and Radiomics Signatures With Machine Learning for Diagnosing Microvascular Invasion. American Journal of Roentgenology 216:6, pages 1510-1520.
Crossref
Shi Li, Yu Liu, Yifeng Bai, Min Chen, Donghui Cheng, Mengwan Wu & Jianling Xia. (2021) Ras Homolog Family Member F, Filopodia Associated Promotes Hepatocellular Carcinoma Metastasis by Altering the Metabolic Status of Cancer Cells Through RAB3D. Hepatology 73:6, pages 2361-2379.
Crossref
Yuki Ohya, Shintaro Hayashida, Akira Tsuji, Kunitaka Kuramoto, Hidekatsu Shibata, Hiroko Setoyama, Hironori Hayashi, Kazumi Kuriwaki, Masato Sasaki, Masayoshi Iizaka, Osamu Nakahara & Yukihiro Inomata. (2020) Conversion hepatectomy for advanced hepatocellular carcinoma after right portal vein transection and lenvatinib therapy. Surgical Case Reports 6:1.
Crossref
Jincheng Feng, Ying He, Junhua Wan & Zhishui Chen. (2020) Pulmonary metastases in newly diagnosed hepatocellular carcinoma: a population-based retrospective study. HPB 22:9, pages 1295-1304.
Crossref
Yidi Chen, Xiali Qin, Liling Long, Ling Zhang, Zhongkui Huang, Zijian Jiang & Chenhui Li. (2019) Diagnostic Value of Gd‐EOB‐DTPA‐Enhanced MRI for the Expression of Ki67 and Microvascular Density in Hepatocellular Carcinoma. Journal of Magnetic Resonance Imaging 51:6, pages 1755-1763.
Crossref
Huiyuan Tian, Shaofeng Cao, Mingxing Hu, Yuzhu Wang, Qiang Fu, Yanfeng Pan & Tao Qin. (2020) Identification of predictive factors in hepatocellular carcinoma outcome: A longitudinal study. Oncology Letters 20:1, pages 765-773.
Crossref
Arash Sarveazad, Shahram Agah, Asrin Babahajian, Naser Amini & Mansour Bahardoust. (2019) Predictors of 5 year survival rate in hepatocellular carcinoma patients. Journal of Research in Medical Sciences 24:1, pages 86.
Crossref